Press Releases Events & Presentations Press Releases Year None20202019201820172016201520142013201220112010 Nov 17, 2020 Assembly Biosciences Appoints Nicole S. White, PhD, as Senior Vice President of Pharmaceutical Development and Manufacturing View HTML PDF Version Nov 16, 2020 Assembly Biosciences and Door Pharmaceuticals Sign Collaboration and Option Agreement to Develop a Novel Class of HBV Core Protein Modulators View HTML PDF Version Nov 13, 2020 Assembly Biosciences Presents Data from HBV Core Inhibitor Programs in Poster Sessions at the 2020 AASLD The Liver Meeting Digital Experience™ View HTML PDF Version Nov 06, 2020 Assembly Biosciences Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) View HTML PDF Version Nov 05, 2020 Assembly Biosciences Reports Third Quarter 2020 Financial Results and Business Update View HTML PDF Version Nov 05, 2020 Assembly Biosciences Provides Update on the Ongoing Phase 2 Extension Study of Vebicorvir in Patients with Chronic Hepatitis B Virus Infection View HTML PDF Version Nov 02, 2020 Multiple Abstracts Highlighting Assembly Biosciences’ Hepatitis B Core Inhibitor Development Programs Accepted for Presentation at the 2020 AASLD The Liver Meeting Digital Experience™ View HTML PDF Version Oct 20, 2020 Assembly Biosciences Appoints Gina Consylman to Board of Directors View HTML PDF Version Oct 15, 2020 Assembly Biosciences CEO Dr. John McHutchison Named Recipient of the Prestigious Advance 2020 Global Impact Award View HTML PDF Version Oct 05, 2020 Assembly Biosciences Announces October Conference Participation View HTML PDF Version Pagination Current page 1 Page 2 Page 3 Page 4 Next page next › Last page last » Shareholder Tools Print Email Alerts Printed Materials RSS News Feeds Search Investors
Press Releases Year None20202019201820172016201520142013201220112010 Nov 17, 2020 Assembly Biosciences Appoints Nicole S. White, PhD, as Senior Vice President of Pharmaceutical Development and Manufacturing View HTML PDF Version Nov 16, 2020 Assembly Biosciences and Door Pharmaceuticals Sign Collaboration and Option Agreement to Develop a Novel Class of HBV Core Protein Modulators View HTML PDF Version Nov 13, 2020 Assembly Biosciences Presents Data from HBV Core Inhibitor Programs in Poster Sessions at the 2020 AASLD The Liver Meeting Digital Experience™ View HTML PDF Version Nov 06, 2020 Assembly Biosciences Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) View HTML PDF Version Nov 05, 2020 Assembly Biosciences Reports Third Quarter 2020 Financial Results and Business Update View HTML PDF Version Nov 05, 2020 Assembly Biosciences Provides Update on the Ongoing Phase 2 Extension Study of Vebicorvir in Patients with Chronic Hepatitis B Virus Infection View HTML PDF Version Nov 02, 2020 Multiple Abstracts Highlighting Assembly Biosciences’ Hepatitis B Core Inhibitor Development Programs Accepted for Presentation at the 2020 AASLD The Liver Meeting Digital Experience™ View HTML PDF Version Oct 20, 2020 Assembly Biosciences Appoints Gina Consylman to Board of Directors View HTML PDF Version Oct 15, 2020 Assembly Biosciences CEO Dr. John McHutchison Named Recipient of the Prestigious Advance 2020 Global Impact Award View HTML PDF Version Oct 05, 2020 Assembly Biosciences Announces October Conference Participation View HTML PDF Version Pagination Current page 1 Page 2 Page 3 Page 4 Next page next › Last page last »
